Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gerd Geisslinger

Showing results (41-50 of 441) with videos related to

Pageof 45
Sort By:
Trends in Pharmacological Sciences|May 13, 2019
Novel Approaches to Persistent Pain TherapyMarco Sisignano, Michael J Parnham, Gerd Geisslinger
Trends in Pharmacological Sciences|December 27, 2015
Drug Repurposing for the Development of Novel AnalgesicsMarco Sisignano, Michael J Parnham, Gerd Geisslinger
BMJ (Clinical Research Ed.)|May 31, 2013
Opioids for chronic non-cancer painRainer Freynhagen, Gerd Geisslinger, Stephan A Schug
Progress in Lipid Research|June 28, 2020
Influence of glycosphingolipids on cancer cell energy metabolismNina Schömel, Gerd Geisslinger, Marthe-Susanna Wegner
Cells|August 27, 2021
Proton-Sensing GPCRs in Health and DiseaseMarco Sisignano, Michael J M Fischer, Gerd Geisslinger
Clinical Pharmacokinetics|November 9, 2004
Genetic predictors of the clinical response to opioid analgesics: clinical utility and future perspectivesJörn Lötsch, Carsten Skarke, Jürgen Liefhold, et al.
British Journal of Clinical Pharmacology|November 26, 2002
Validation of a new fluorogenic real-time PCR assay for detection of CYP2C9 allelic variants and CYP2C9 allelic distribution in a German populationMaria Burian, Sabine Grösch, Irmgard Tegeder, et al.
Mutation Research. Reviews in Mutation Research|March 14, 2012
The pharmacogenetic background of hepatitis C treatmentChristina Schlecker, Alfred Ultsch, Gerd Geisslinger, et al.
Pharmacological Reviews|March 26, 2011
SNO-ing at the nociceptive synapse?Irmgard Tegeder, Reynir Scheving, Ilka Wittig, et al.
European Journal of Clinical Pharmacology|November 25, 2005
Rapid genotyping for relevant CYP1A2 alleles by pyrosequencingCarsten Skarke, Anja Kirchhof, Gerd Geisslinger, et al.
Pageof 45

Showing results (41-50 of 441) with videos related to

Sort By:
Pageof 45
Trends in Pharmacological Sciences|May 13, 2019
Novel Approaches to Persistent Pain TherapyMarco Sisignano, Michael J Parnham, Gerd Geisslinger
Trends in Pharmacological Sciences|December 27, 2015
Drug Repurposing for the Development of Novel AnalgesicsMarco Sisignano, Michael J Parnham, Gerd Geisslinger
BMJ (Clinical Research Ed.)|May 31, 2013
Opioids for chronic non-cancer painRainer Freynhagen, Gerd Geisslinger, Stephan A Schug
Progress in Lipid Research|June 28, 2020
Influence of glycosphingolipids on cancer cell energy metabolismNina Schömel, Gerd Geisslinger, Marthe-Susanna Wegner
Cells|August 27, 2021
Proton-Sensing GPCRs in Health and DiseaseMarco Sisignano, Michael J M Fischer, Gerd Geisslinger
Clinical Pharmacokinetics|November 9, 2004
Genetic predictors of the clinical response to opioid analgesics: clinical utility and future perspectivesJörn Lötsch, Carsten Skarke, Jürgen Liefhold, et al.
British Journal of Clinical Pharmacology|November 26, 2002
Validation of a new fluorogenic real-time PCR assay for detection of CYP2C9 allelic variants and CYP2C9 allelic distribution in a German populationMaria Burian, Sabine Grösch, Irmgard Tegeder, et al.
Mutation Research. Reviews in Mutation Research|March 14, 2012
The pharmacogenetic background of hepatitis C treatmentChristina Schlecker, Alfred Ultsch, Gerd Geisslinger, et al.
Pharmacological Reviews|March 26, 2011
SNO-ing at the nociceptive synapse?Irmgard Tegeder, Reynir Scheving, Ilka Wittig, et al.
European Journal of Clinical Pharmacology|November 25, 2005
Rapid genotyping for relevant CYP1A2 alleles by pyrosequencingCarsten Skarke, Anja Kirchhof, Gerd Geisslinger, et al.
Pageof 45